Ando Y, Jacobson H R, Breyer M D
J Clin Invest. 1987 Aug;80(2):590-3. doi: 10.1172/JCI113110.
We explored the role for protein kinase C (PKC) in modulating vasopressin (AVP)-stimulated hydraulic conductivity (Lp) in rabbit cortical collecting tubule (CCT) perfused in vitro at 37 degrees C. In control studies, 10 microU/ml AVP increased Lp (mean +/- SE, X 10(-7) centimeters/atmosphere per second) from 4.4 +/- 0.9 to 166.0 +/- 10.4. Pretreatment with dioctanoylglycerol (DiC8) suppressed AVP stimulated peak Lp (peak Lp, 21.9 +/- 3.1). Pretreatment with 10(-9) and 10(-7) M 4 beta-phorbol 12 beta-myristate 13 alpha-acetate (PMA) also blocked the increase in Lp in a dose-dependent fashion (peak Lp, 59.3 +/- 7.5 and 18.6 +/- 4.8, respectively). Inactive phorbol ester, 4 alpha-phorbol 12 beta,13 alpha-didecanoate (10(-7) M), had no effect. PMA also suppressed the increase in Lp induced by 10(-4) M 8-p-chlorophenylthio-cyclic AMP (CcAMP): peak Lp was 169.4 +/- 14.9 in control, 79.2 +/- 5.5 with 10(-9) M PMA, and 25.7 +/- 2.9 with 10(-7) M PMA. Furthermore, when 10(-7) M PMA was added to the bath 10 min after exposure to AVP, the Lp response to AVP was blocked. Peak Lp was 52.4 +/- 9.6 with PMA vs. 165.1 +/- 10.0 in control. Phosphatidic acid (PA), which is thought to stimulate phosphatidylinositol (PI) turnover, produced similar inhibitory effects on AVP as well as CcAMP-stimulated Lp: PA suppressed 10-microU/ml AVP-induced peak Lp from a control value of 159.6 +/- 7.9 to 88.9 +/- 15.8, and 10(-4) M CcAMP induced peak Lp from 169.4 +/- 14.9 to 95.5 +/- 7.7. We conclude that PMA, at concentrations known to specifically activate PKC, suppresses the hydroosmotic effect of AVP on CCT; This suppression is primarily a post-cAMP event; Inhibition of AVP-stimulated Lp by DiC8 and PA also suggests an inhibitory role for the PKC system; The ability of pre- and post-AVP administration of PMA to blunt the AVP response suggests that agents that act through modulation of PI turnover in CCT may regulate the hydroosmotic effect of AVP.
我们研究了蛋白激酶C(PKC)在调节37℃体外灌注的兔皮质集合管(CCT)中血管加压素(AVP)刺激的水通透率(Lp)方面的作用。在对照研究中,10微单位/毫升的AVP使Lp(平均值±标准误,×10⁻⁷厘米/大气压每秒)从4.4±0.9增加到166.0±10.4。用二辛酰甘油(DiC8)预处理可抑制AVP刺激的Lp峰值(峰值Lp,21.9±3.1)。用10⁻⁹和10⁻⁷摩尔/升的4β - 佛波醇12β - 肉豆蔻酸13α - 乙酸酯(PMA)预处理也以剂量依赖性方式阻断Lp的增加(峰值Lp分别为59.3±7.5和18.6±4.8)。无活性的佛波醇酯4α - 佛波醇12β,13α - 二十二酸酯(10⁻⁷摩尔/升)无作用。PMA还抑制了10⁻⁴摩尔/升的8 - 对氯苯硫基环磷酸腺苷(CcAMP)诱导的Lp增加:对照中峰值Lp为169.4±14.9,10⁻⁹摩尔/升PMA时为79.2±5.5,10⁻⁷摩尔/升PMA时为25.7±2.9。此外,当在暴露于AVP 10分钟后向浴槽中加入10⁻⁷摩尔/升PMA时,对AVP的Lp反应被阻断。PMA时峰值Lp为52.4±9.6,对照中为165.1±10.0。被认为可刺激磷脂酰肌醇(PI)周转的磷脂酸(PA)对AVP以及CcAMP刺激的Lp产生类似的抑制作用:PA将10微单位/毫升AVP诱导的峰值Lp从对照值159.6±7.9抑制到88.9±15.8,将10⁻⁴摩尔/升CcAMP诱导峰值Lp从169.4±14.9抑制到95.5±7.7。我们得出结论,已知能特异性激活PKC的浓度下的PMA可抑制AVP对CCT的水渗透作用;这种抑制主要是cAMP后的事件;DiC8和PA对AVP刺激的Lp的抑制也表明PKC系统具有抑制作用;AVP给药前和给药后PMA减弱AVP反应的能力表明,通过调节CCT中PI周转起作用的药物可能调节AVP的水渗透作用。